Open AccessUse of Renin-Angiotensin Inhibitors in People with Renal Artery Stenosis
Author(s) -
Kaleigh L. Evans,
Katherine R. Tuttle,
David A Folt,
Taylor Dawson,
Steven T. Haller,
Pamela Brewster,
Wencan He,
Kenneth Jamerson,
Lance D. Dworkin,
Donald E. Cutlip,
Timothy F. Murphy,
Ralph B. D’Agostino,
William L. Henrich,
Christopher J. Cooper
Publication year - 2014
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.11611113
Subject(s) - medicine , renin–angiotensin system , renal artery stenosis , renal function , cardiology , angiotensin ii , diabetes mellitus , ace inhibitor , angiotensin converting enzyme , heart failure , angiotensin receptor , renal artery , kidney , endocrinology , urology , blood pressure
People with atherosclerotic renal artery stenosis may benefit from renin-angiotensin inhibitors, angiotensin-converting enzyme inhibitors, and angiotensin-receptor blockers, but little is known about the factors associated with their use.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom